Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 68
Selected: 0
NCT IDTitle
NCT06496048Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
NCT04973722A Study to Evaluate LY06006 and Prolia in Healthy Adults
NCT02055274Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
NCT05862974A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects
NCT03822065A Relative Bioavailability Food Effect Study of LY03005
NCT03589066Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
NCT06556966A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
NCT05865925Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors
NCT03533127A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer
NCT06095427A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection
NCT04630860A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD
NCT06204120Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery
NCT03733574A Study of LY03005 vs Pristiq
NCT04384666A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers
NCT04638491Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors Patients
NCT04973735A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects
NCT05856630Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg
NCT03357796Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®
NCT04627155A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003
NCT06793995Effect of Food and Age on the Pharmacokinetics of LY03017
NCT04629404A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients
NCT05238701A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects
NCT02988024Pilot BA Study of New LY03005 vs Pristiq
NCT04571164A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD
NCT05321602Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
NCT03844438A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors
NCT02186769An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
NCT05140512Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
NCT04381910Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer
NCT05970510A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
NCT06474650Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets
NCT02271412Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
NCT06240546First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.
NCT04859569Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors
NCT06731868Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
NCT06247410Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease
NCT04563936Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
NCT04198636A Study to Evaluate LY01011 and Xgeva® in Healthy Adults
NCT05060406A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture
NCT06098599Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast Cancer
NCT03427853A Study to Evaluate the Denosumab in Healthy Adults
NCT06388551A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017
NCT04922593Relative Bioavailability of LY03010 Compared to Listed Drug
NCT05853341Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)
NCT02603770Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
NCT04853407A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
NCT06467409Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery
NCT06426485To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
NCT04572685Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
NCT02091388Bioavailability of LY03004 and Risperdal® Consta®